STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

March 6, 2026

Period of Report

March 4, 2026

Accession Number

0001780851-26-000005